Literature DB >> 20509019

[Wilson's disease and Westphal-Strümpell pseudosclerosis: conceptual history in German-speaking countries].

P Boide1, A Wagner, H Steinberg.   

Abstract

The article investigates the hitherto little elaborated conceptual history of Wilson's hepatolenticular degeneration and Westphal's pseudosclerosis from the mid-nineteenth century up to present day, mainly in German-speaking countries. This disease exemplifies how neurological diseases have come into existence and also demonstrates how clinical descriptions of a few isolated cases merge into a nosological diagnosis, how recognized therapeutic measures are developed and how the underlying genetic causes are identified. For some time German-speaking neurologists were in disagreement about whether or not a disease described by Carl Westphal in 1883 was identical with one described by and later named after Kinnier Wilson. This article presents the publications by Adolf Strümpell, Alois Alzheimer, August Bostroem and Walther Spielmeyer as the major contributions of German-speaking specialists to a deeper understanding of an illness and investigates whether or not the two disease concepts represent identical illnesses or not. From 1970 onwards the "Morbus Wilson Center" in Leipzig became important for the development of recognized therapeutic measures and their application in medical practice in Eastern Germany (the former GDR) and its findings have been incorporated in the present Guidelines of the German Society for Neurology published in 2008 for the treatment of Wilson's disease.

Entities:  

Mesh:

Year:  2011        PMID: 20509019     DOI: 10.1007/s00115-010-3030-8

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  21 in total

1.  S.A. Kinnier Wilson (1878-1937).

Authors:  T U Hoogenraad
Journal:  J Neurol       Date:  2001-01       Impact factor: 4.849

2.  Penicillamine, a new oral therapy for Wilson's disease.

Authors:  J M WALSHE
Journal:  Am J Med       Date:  1956-10       Impact factor: 4.965

3.  Studies on copper metabolism in demyelinating diseases of the central nervous system.

Authors:  B M MANDELBROTE; M W STANIER
Journal:  Brain       Date:  1948-06       Impact factor: 13.501

4.  The effects of B.A.L. in hepatolenticular degeneration.

Authors:  J N CUMINGS
Journal:  Brain       Date:  1951-03       Impact factor: 13.501

5.  [Wilson's disease in the German Democratic Republic. I. Genetics and epidemiology].

Authors:  H Bachmann; J Lössner; D Biesold
Journal:  Z Gesamte Inn Med       Date:  1979-12-15

6.  [Classification of Wilson's disease based on neurophysiological parameters].

Authors:  W Hermann; P Günther; A Wagner; T Villmann
Journal:  Nervenarzt       Date:  2005-06       Impact factor: 1.214

7.  Classification of fine-motoric disturbances in Wilson's disease using artificial neural networks.

Authors:  W Hermann; A Wagner; H-J Kühn; F Grahmann; T Villmann
Journal:  Acta Neurol Scand       Date:  2005-06       Impact factor: 3.209

8.  The degree of depression in Hamilton rating scale is correlated with the density of presynaptic serotonin transporters in 23 patients with Wilson's disease.

Authors:  B Eggers; W Hermann; H Barthel; O Sabri; A Wagner; S Hesse
Journal:  J Neurol       Date:  2003-05       Impact factor: 4.849

9.  Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride.

Authors:  J M Walshe
Journal:  Lancet       Date:  1982-03-20       Impact factor: 79.321

10.  Liver transplantation for Wilson's disease: indications and outcome.

Authors:  M L Schilsky; I H Scheinberg; I Sternlieb
Journal:  Hepatology       Date:  1994-03       Impact factor: 17.425

View more
  2 in total

1.  Adolf von Strümpell: a key yet neglected protagonist of neurology.

Authors:  Birk Engmann; Armin Wagner; Holger Steinberg
Journal:  J Neurol       Date:  2012-04-19       Impact factor: 4.849

Review 2.  [History of neurology in the GDR: a systematic review].

Authors:  Jan Armbruster; Matthias Grothe; Kathleen Haack; Ekkehardt Kumbier
Journal:  Nervenarzt       Date:  2022-07-12       Impact factor: 1.297

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.